title: Modulation of thalamic nociceptive processing after spinal cord injury through remote activation of thalamic microglia by cysteine cysteine chemokine ligand 21.
abstract: Spinal cord injury (SCI) results in the generation and amplification of pain caused in part by injury-induced changes in neuronal excitability at multiple levels along the sensory neuraxis. We have previously shown that activated microglia, through an ERK (extracellular signal-regulated kinase)-regulated PGE(2) (prostaglandin E(2)) signaling mechanism, maintain neuronal hyperexcitability in the lumbar dorsal horn. Here, we examined whether microglial cells in the thalamus contribute to the modulation of chronic pain after SCI, and whether microglial activation is governed by spinally mediated increases in the microglial activator cysteine-cysteine chemokine ligand 21 (CCL21). We report that CCL21 is upregulated in dorsal horn neurons, that tissue levels are increased in the dorsal horn and ventral posterolateral (VPL) nucleus of the thalamus 4 weeks after SCI, and that the increase can be differentially reduced by spinal blockade at T1 or L1. In intact animals, electrical stimulation of the spinothalamic tract induces increases in thalamic CCL21 levels. Recombinant CCL21 injected into the VPL of intact animals transiently activates microglia and induces pain-related behaviors, effects that could be blocked with minocycline. After SCI, intra-VPL antibody-mediated neutralization of CCL21 decreases microglial activation and evoked hyperexcitability of VPL neurons, and restores nociceptive thresholds to near-normal levels. These data identify a novel pathway by which SCI triggers upregulation of the neuroimmune modulator CCL21 in the thalamus, which induces microglial activation in association with pain phenomena.
authors: Department of Neurology and Center for Neuroscience and Regeneration Research, Yale University School of Medicine, New Haven, Connecticut 06510, USA.
authors: Peng
authors: P
authors: Zhao
authors: Stephen G
authors: SG
authors: Waxman
authors: Bryan C
authors: BC
authors: Hains
mesh_terms: D000818:Animals; D001522:Behavior, Animal; D054421:Chemokine CCL21; D019742:Chemokines, CC / Q000378:metabolism* / Q000494:pharmacology; D004195:Disease Models, Animal; D004558:Electric Stimulation / Q000379:methods; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D007839:Functional Laterality; D005786:Gene Expression Regulation / Q000502:physiology / Q000528:radiation effects; D008297:Male; D017628:Microglia / Q000187:drug effects*; D010146:Pain / Q000209:etiology* / Q000378:metabolism*; D017288:Pain Threshold / Q000187:drug effects / Q000502:physiology / Q000528:radiation effects; D010751:Phosphopyruvate Hydratase / Q000378:metabolism; D020671:Posterior Horn Cells / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D013119:Spinal Cord Injuries / Q000150:complications / Q000473:pathology / Q000503:physiopathology; D020651:Ventral Thalamic Nuclei / Q000378:metabolism / Q000473:pathology*
chemical_list: D054421:Chemokine CCL21; D019742:Chemokines, CC; D010751:Phosphopyruvate Hydratase
references: Brain Res. 1989 Sep 4;496(1-2):357-60
references: 2804648
references: J Neurosci. 2003 May 15;23(10):4017-22
references: 12764087
references: Trends Neurosci. 2006 Apr;29(4):207-15
references: 16494954
references: J Immunol. 2004 Mar 1;172(5):2744-7
references: 14978072
references: J Comp Neurol. 1997 Jan 20;377(3):443-64
references: 8989657
references: Annu Rev Pharmacol Toxicol. 1980;20:441-62
references: 7387124
references: Exp Neurol. 2006 Jan;197(1):177-88
references: 16266704
references: J Neuroinflammation. 2005 Jan 28;2(1):5
references: 15679892
references: J Neurochem. 2005 Nov;95(4):998-1014
references: 16219025
references: Brain Res Rev. 2006 Aug;51(2):240-64
references: 16388853
references: J Neurosci. 2005 Aug 17;25(33):7548-57
references: 16107642
references: J Neurosci. 2004 Sep 29;24(39):8500-9
references: 15456824
references: J Neuropathol Exp Neurol. 2006 Feb;65(2):124-41
references: 16462204
references: Spinal Cord. 2007 Feb;45(2):174-82
references: 16505827
references: AJNR Am J Neuroradiol. 2002 Jun-Jul;23(6):901-5
references: 12063213
references: Brain. 2005 Oct;128(Pt 10):2359-71
references: 16109750
references: J Neurophysiol. 1991 Sep;66(3):1033-47
references: 1753274
references: Pharmacol Rev. 2000 Mar;52(1):145-76
references: 10699158
references: Blood. 2005 Jan 1;105(1):31-9
references: 15358618
references: Eur J Neurosci. 2004 Nov;20(9):2294-302
references: 15525271
references: Eur J Neurosci. 2005 Nov;22(10):2431-40
references: 16307586
references: J Neurosci Methods. 1994 Jul;53(1):55-63
references: 7990513
references: Sci STKE. 2004 Sep 21;2004(252):reE14
references: 15454629
references: J Neurophysiol. 2006 Jun;95(6):3343-52
references: 16481457
references: J Neurosci Methods. 1980 Dec;3(2):129-49
references: 6110810
references: J Neurosci. 2007 Feb 28;27(9):2357-68
references: 17329433
references: Trends Neurosci. 2001 Aug;24(8):450-5
references: 11476884
references: Glia. 1998 May;23(1):75-83
references: 9562186
references: Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):14092-7
references: 16174730
references: Neurosignals. 2005;14(4):166-74
references: 16215299
references: Nat Rev Neurosci. 2005 Jul;6(7):521-32
references: 15995723
references: Brain Pathol. 2003 Jan;13(1):38-51
references: 12580544
references: J Comp Neurol. 2003 Jul 21;462(2):223-40
references: 12794745
references: Glia. 2006 Dec;54(8):861-72
references: 16977602
references: Trends Neurosci. 2005 Feb;28(2):101-7
references: 15667933
references: Brain Behav Immun. 2007 Feb;21(2):131-46
references: 17175134
references: Exp Neurol. 1999 Oct;159(2):538-44
references: 10506525
references: Brain Res. 1999 Apr 17;825(1-2):59-67
references: 10216173
references: J Exp Med. 1999 Feb 1;189(3):451-60
references: 9927507
references: Brain Res. 1993 May 28;612(1-2):345-50
references: 8101136
references: Nat Neurosci. 2001 Apr;4(4):402-8
references: 11276231
references: Prog Brain Res. 2000;129:429-49
references: 11098709
references: Neuroscience. 2000;101(2):393-401
references: 11074162
references: J Pharmacol Exp Ther. 2003 Aug;306(2):624-30
references: 12734393
references: J Neurosci. 2003 Oct 1;23(26):8881-92
references: 14523090
references: J Immunol. 2002 Apr 1;168(7):3221-6
references: 11907075
references: Pain. 2006 May;122(1-2):17-21
references: 16564626
references: Eur J Neurosci. 2005 Dec;22(11):2775-82
references: 16324111
references: J Neurosci Methods. 1997 Oct 3;76(2):183-91
references: 9350970
references: Glia. 2006 Jul;54(1):58-70
references: 16715500
references: J Neurotrauma. 1992 Summer;9(2):123-6; discussion 126-8
references: 1404425
references: Glia. 2005 May;50(3):247-57
references: 15739189
references: J Neurosci. 2001 Apr 15;21(8):2808-19
references: 11306633
references: Eur J Neurosci. 2004 Sep;20(5):1150-60
references: 15341587
references: Neuroscience. 2002;112(3):487-97
references: 12074892
references: Glia. 2001 Apr 15;34(2):121-33
references: 11307161
references: Neuroscience. 1998 Jul;85(2):331-45
references: 9622234
references: J Neurosci. 2006 Apr 19;26(16):4308-17
references: 16624951
references: Brain Behav Immun. 2007 Jul;21(5):660-7
references: 17204394
references: Nat Rev Drug Discov. 2005 Oct;4(10):834-44
references: 16224455
references: Exp Neurol. 2006 Jun;199(2):397-407
references: 16478624
references: J Neurophysiol. 1990 Nov;64(5):1400-12
references: 2178182
references: J Neurochem. 2006 May;97(3):772-83
references: 16524371
references: Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8205-10
references: 9653165
references: Neuroscience. 2003;117(3):715-22
references: 12617975
references: Hum Gene Ther. 2006 Aug;17(8):859-70
references: 16942445
references: Pain. 2005 May;115(1-2):71-83
references: 15836971